EyeGate VP Engineering Michael Manzo departs as of Aug 20, 2021

KIORA PHARMACEUTICALS INC

Michael Manzo ceased serving as VP of Engineering effective August 20, 2021.
No replacement has been announced; remaining executive team unchanged.
Departure follows customary transition; no reason provided in filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Manzo

Vice President of Engineering

KPRX · KIORA PHARMACEUTICALS INC

Effective: 2021-08-20
Filed: August 26, 2021, 7:59 PM ET

Effective as of August 20, 2021, Michael Manzo ceased serving as the Vice President of Engineering of EyeGate Pharmaceuticals, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Manzo departed as Vice President of Engineering at KIORA PHARMACEUTICALS INC.

Action: ceased serving
Role: Vice President of Engineering

Exact text from the filing

Effective as of August 20, 2021, Michael Manzo ceased serving as the Vice President of Engineering of EyeGate Pharmaceuticals, Inc.

View on SEC.gov

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-21-109807

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.